Assessment of Simulated Surveillance Testing and Quarantine in a SARS-CoV-2-Vaccinated Population of Students on a University Campus.

dc.contributor.author

Motta, Francis C

dc.contributor.author

McGoff, Kevin A

dc.contributor.author

Deckard, Anastasia

dc.contributor.author

Wolfe, Cameron R

dc.contributor.author

Bonsignori, Mattia

dc.contributor.author

Moody, M Anthony

dc.contributor.author

Cavanaugh, Kyle

dc.contributor.author

Denny, Thomas N

dc.contributor.author

Harer, John

dc.contributor.author

Haase, Steven B

dc.date.accessioned

2022-09-01T18:10:57Z

dc.date.available

2022-09-01T18:10:57Z

dc.date.issued

2021-10

dc.date.updated

2022-09-01T18:10:56Z

dc.description.abstract

Importance

The importance of surveillance testing and quarantine on university campuses to limit SARS-CoV-2 transmission needs to be reevaluated in the context of a complex and rapidly changing environment that includes vaccines, variants, and waning immunity. Also, recent US Centers for Disease Control and Prevention guidelines suggest that vaccinated students do not need to participate in surveillance testing.

Objective

To evaluate the use of surveillance testing and quarantine in a fully vaccinated student population for whom vaccine effectiveness may be affected by the type of vaccination, presence of variants, and loss of vaccine-induced or natural immunity over time.

Design setting and participants

In this simulation study, an agent-based Susceptible, Exposed, Infected, Recovered model was developed with some parameters estimated using data from the 2020 to 2021 academic year at Duke University (Durham, North Carolina) that described a simulated population of 5000 undergraduate students residing on campus in residential dormitories. This study assumed that 100% of residential undergraduates are vaccinated. Under varying levels of vaccine effectiveness (90%, 75%, and 50%), the reductions in the numbers of positive cases under various mitigation strategies that involved surveillance testing and quarantine were estimated.

Main outcomes and measures

The percentage of students infected with SARS-CoV-2 each day for the course of the semester (100 days) and the total number of isolated or quarantined students were estimated.

Results

A total of 5000 undergraduates were simulated in the study. In simulations with 90% vaccine effectiveness, weekly surveillance testing was associated with only marginally reduced viral transmission. At 50% to 75% effectiveness, surveillance testing was estimated to reduce the number of infections by as much as 93.6%. A 10-day quarantine protocol for exposures was associated with only modest reduction in infections until vaccine effectiveness dropped to 50%. Increased testing of reported contacts was estimated to be at least as effective as quarantine at limiting infections.

Conclusions and relevance

In this simulated modeling study of infection dynamics on a college campus where 100% of the student body is vaccinated, weekly surveillance testing was associated with a substantial reduction of campus infections with even a modest loss of vaccine effectiveness. Model simulations also suggested that an increased testing cadence can be as effective as a 10-day quarantine period at limiting infections. Together, these findings provide a potential foundation for universities to design appropriate mitigation protocols for the 2021 to 2022 academic year.
dc.identifier

aoi210046

dc.identifier.issn

2689-0186

dc.identifier.issn

2689-0186

dc.identifier.uri

https://hdl.handle.net/10161/25649

dc.language

eng

dc.publisher

American Medical Association (AMA)

dc.relation.ispartof

JAMA health forum

dc.relation.isversionof

10.1001/jamahealthforum.2021.3035

dc.title

Assessment of Simulated Surveillance Testing and Quarantine in a SARS-CoV-2-Vaccinated Population of Students on a University Campus.

dc.type

Journal article

duke.contributor.orcid

Wolfe, Cameron R|0000-0002-5365-5030

duke.contributor.orcid

Moody, M Anthony|0000-0002-3890-5855

duke.contributor.orcid

Haase, Steven B|0000-0001-8127-8992

pubs.begin-page

e213035

pubs.issue

10

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Trinity College of Arts & Sciences

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Immunology

pubs.organisational-group

Medicine

pubs.organisational-group

Pediatrics

pubs.organisational-group

Medicine, Duke Human Vaccine Institute

pubs.organisational-group

Medicine, Infectious Diseases

pubs.organisational-group

Pediatrics, Infectious Diseases

pubs.organisational-group

Biology

pubs.organisational-group

Duke Human Vaccine Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Duke Global Health Institute

pubs.publication-status

Published

pubs.volume

2

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMID35977169.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format